LONDON—ClinTec International last year celebrated being awarded Scale-Up Business of the Year—as well as founder and CEO Dr. Rabinder Buttar being honored as a finalist for Entrepreneur of the Year—at the 5th Minority Supplier Development Network UK’s (MSDUK) awards ceremony.
The event was hosted by British television comedian and playwright Meera Syal, with Paralympics presenter and wheelchair basketball player Ade Adepitan giving the keynote speech. In attendance were top pharmas GlaxoSmithKline, Bristol-Myers Squibb and Merck Sharp & Dohme, as well as other diverse organizations like IBM and Coca-Cola.
The Scale-Up Business of the Year award, sponsored by Ernst and Young, recognized ClinTec’s dynamic and entrepreneurial emergence onto the global stage as a clinical research organization (CRO) and functional service provider. Earlier at the MSDUK annual conference, Buttar took part in a panel discussion, sponsored by Coca-Cola, on how to scale up a business.
A multiple award-winning and woman-majority-owned full-service CRO which embraces diversity, ClinTec was formed nearly 20 years ago by Buttar. With capabilities in more than 80 countries, ClinTec aims to deliver “innovative, customized clinical research solutions and talented functional services to the clinical development sector in a fast, flexible and focused way.”
ClinTec provides services to seven of the world’s top 10 pharmaceutical companies, leading mid-market biopharmaceutical organizations and small- and medium-sized biotechnology companies.
MSDUK, which is celebrating its 10-year anniversary, seeks to recognize purchasing organizations and the talented and entrepreneurial ethnic minority businesses in the United Kingdom for their collaborative efforts to make supply chains both inclusive and competitive. MSDUK was founded by businessman Mayank Shah in 2006 as a vehicle to assist the entrepreneurial ethnic minority business community to realize their ambitions.
As Buttar said at the event, “I am thrilled to accept this prestigious award on behalf of ClinTec International in recognition of our ongoing expansion both in service lines and in geographical reach. As founder of the organization, I have always believed that further success comes from the early recognition not only of what our clients want today, but also will want in the future, and then having the courage to build my company along those lines with the support of my team.
“Embracing diversity has always been a core pillar of ClinTec in building and developing a global team of experts in clinical research. This award endorses that approach and also recognizes the major contributions made by ClinTec’s management team and staff in building for our future success. This endorsement puts our achievements on the map and enhances our reputation with current and future clients.”
This late-2016 award highlighted a successful year by ClinTec on that front, after being named Best Mid-Sized Pharmaceutical CRO in the UK by Global Health and Pharma magazine’s International Life Science Awards in June 2016 and as a finalist in the International Business and Export category at the Scottish Life Science awards in February 2016.
